Industry Trends: CDMO Outsourcing
A recent Industry Standard Research (ISR) study explored CDMO outsourcing models to discover patterns within the selection of CDMO partners that sponsors choose at various stages of development, as well as to determine why sponsors made those choices. Partnering with small/niche CDMOs during early-stage development is attractive to sponsors, in part, because those providers are perceived to be more accessible, offering more interaction with expertise early in development to aid in troubleshooting and other problem-solving. By the time Phase III trials or commercial manufacturing commence, respondents prefer global CDMOs because of those providers’ perceived aptitude in fulfilling demands for global recruitment, manufacturing scale, and regulatory support, among other factors.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.